Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals reported Q1FY26 Total Income of Rs 347.6 crore, up 20.5% YoY, driven by 19.6% growth in IPD revenue and 15.5% growth in OPD revenue. EBITDA rose 19.6% to Rs 78.1 crore with margins largely flat at 22.5%, supported by improved occupancy and a 12.7% rise in ARPOB to Rs 67,300. However, PAT slipped 1.6% YoY to Rs 43.9 crore as depreciation jumped Rs 10.2 crore (capitalisation of new beds) and finance costs rose Rs 7.2 crore (expansion debt). The company outlined a major capacity expansion plan: Dombivli (500 beds, Q1FY27), Pune II Bibwewadi (500 beds, CY28), and Mira-Bhayandar (300 beds, CY29), taking total bed capacity from 1,061 to ~2,500. It also commissioned a 1.2 MW solar plant in Madhya Pradesh, taking renewable energy capacity to 6.8 MW.
Short-term PAT growth is likely to remain soft because management has explicitly guided that the gap between EBITDA and PBT will widen further from rising finance costs and depreciation tied to expansion. This near-term earnings pressure may weigh on the stock, though the ~1,440-bed pipeline over the next 3-4 years supports a longer-term growth story.